Evidence map›Paper›PMID 26448203›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

Central Nervous Insulin Signaling in Sleep-Associated Memory Formation and Neuroendocrine Regulation.

Gordon B Feld, Ines Wilhem, Christian Benedict, Benjamin Rüdel, Corinna Klameth, Jan Born, Manfred Hallschmid

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. eNeuro · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Molecular Mechanisms of Intranasal Insulin in SAMP8 Mice.Journal of Alzheimer's disease : JAD · 2019
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Gordon B FeldInstitute of Medical Psychology and Behavioral Neurobiology, University of Tuebingen, Tuebingen, Germany.
Ines WilhemChild Development Center, University Children's Hospital Zurich, Zurich, Switzerland.
Christian BenedictDepartment of Neuroscience, Uppsala University, Uppsala, Sweden.
Benjamin RüdelInstitute of Medical Psychology and Behavioral Neurobiology, University of Tuebingen, Tuebingen, Germany.
Corinna KlamethInstitute of Medical Psychology and Behavioral Neurobiology, University of Tuebingen, Tuebingen, Germany.
Jan BornInstitute of Medical Psychology and Behavioral Neurobiology, University of Tuebingen, Tuebingen, Germany.
Manfred HallschmidInstitute of Medical Psychology and Behavioral Neurobiology, University of Tuebingen, Tuebingen, Germany.
University of Tübingen · DEGerman Center for Diabetes Research · DEUniversity Children's Hospital Zurich · CHUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neurochemical underpinnings of sleep's contribution to the establishment and maintenance of memory traces are largely unexplored. Considering that intranasal insulin administration to the CNS improves memory functions in healthy and memory-impaired humans, we tested whether brain insulin signaling and sleep interact to enhance memory consolidation in healthy participants. We investigated the effect of intranasal insulin on sleep-associated neurophysiological and neuroendocrine parameters and memory consolidation in 16 men and 16 women (aged 18-30 years), who learned a declarative word-pair task and a procedural finger sequence tapping task in the evening before intranasal insulin (160 IU) or placebo administration and 8 h of nocturnal sleep. On the subsequent evening, they learned interfering word-pairs and a new finger sequence before retrieving the original memories. Insulin increased growth hormone concentrations in the first night-half and EEG delta power during the second 90 min of non-rapid-eye-movement sleep. Insulin treatment impaired the acquisition of new contents in both the declarative and procedural memory systems on the next day, whereas retrieval of original memories was unchanged. Results indicate that sleep-associated memory consolidation is not a primary mediator of insulin's acute memory-improving effect, but that the peptide acts on mechanisms that diminish the subsequent encoding of novel information. Thus, by inhibiting processes of active forgetting during sleep, central nervous insulin might reduce the interfering influence of encoding new information.

Indexed as

Administration, IntranasalAdolescentAdultBlood GlucoseBrainCross-Over StudiesDelta RhythmDouble-Blind MethodFemaleHumansInsulinMaleMemory ConsolidationSleepYoung AdultBlood GlucoseInsulin

Identifiers

PMID26448203
PMCPMC4832015
OpenAlexW2325925647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.